International Immunology Advance Access originally published online on April 8, 2008
International Immunology 2008 20(6):775-782; doi:10.1093/intimm/dxn035
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Osteoclasts support the survival of human plasma cells in vitro
1 INSERM U601, Department of Cancer Research, Biology Institute, 9 Quai Moncousu, F-44000 Nantes, France
2 Université de Nantes, Nantes Atlantique Universités, Nantes, France
3 Centre de Lutte Contre Le Cancer Nantes Atlantique, Saint-Herblain, France
Correspondence to: C. Pellat-Deceunynck; E-mail: cpellat{at}nantes.inserm.fr
The aim of this in vitro study was to evaluate if osteoclasts (OCs) and dendritic cells (DCs), both of monocyte origin, can support the survival of normal human plasma cells (PCs). PCs differentiate from plasmablasts (PBs) arising from activated B cells, essentially memory B cells. To study the survival of both PBs (CD20lowCD38highCD138neg) and PCs (CD20negCD38brightCD138bright), we generated pre-PBs (CD20lowCD38posCD138neg) from CD40-activated B cells (CD20highCD38negCD138neg) and cultured them on DCs or OCs in the presence of added IL-6. By quantitative and qualitative study, we showed that DCs support the survival of PBs and early PCs, but not that of PCs. In contrast, OCs support the survival of PBs, early PCs and PCs. PCs surviving on OCs 12 days after pre-PB input display phenotypic features of bone marrow PCs, CD138brightCD38brightHLA-DRlowCD45dim. The ability for OCs to support the survival of PCs was fully dependent on cell–cell contact and not inhibited by BCMA-Fc suggesting that secreted BAFF and APRIL were not involved.
Keywords: dendritic cells, osteoclasts, plasma cells, survival
Transmitting editor: A. Radbruch
Received 6 November 2007, revised 3 March 2008, accepted 8 March 2008.